Barclays Capital rated Cymer, Inc. (NASDAQ:CYMI) Equal Weight and changed its price target from $42.00 to $37.00. The shares recently traded at $39.28, down $0.24, or 0.61%, on the day. The shares have traded in a 52-week range of $33.89 to $58.19 and its market capitalization is $1.2 billion. About the company: Cymer, Inc. supplies excimer laser illumination sources for use in deep ultraviolet photolithography systems. The Company’s lasers are incorporated into step-and-repeat and step-and-scan photolithography systems for use in the manufacture of semiconductors.
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>